Learning to BREATHE: A Randomized Controlled Trial to Lower Diabetes Risk in Adolescent Girls

NCT ID: NCT02218138

Last Updated: 2020-03-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

35 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-01-31

Study Completion Date

2016-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Type 2 diabetes is a chronic disease that puts people at risk for major health problems like heart disease. Type 2 diabetes is the most common type of diabetes in adults. However, there has been a concerning rise in type 2 diabetes among teenagers. Diabetes develops through poor insulin sensitivity, meaning that insulin - an important chemical the body makes to keep blood sugar normal - isn't working properly. Type 2 diabetes can be prevented by improving insulin sensitivity. Stress is related to insulin sensitivity. Individuals who feel stressed have worse insulin sensitivity than individuals who do not feel stressed. In adults, decreasing stress leads to improvements in insulin sensitivity, but this hasn't been tested in teenagers. The purpose of this study is to find out if taking part in a brief group program to decrease stress will improve insulin sensitivity and lower diabetes risk in teenage girls.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

After a screening to determine eligibility, girls are randomly assigned to take part in one of two 6-week group programs: 1) Learning to BREATHE - a mindfulness-based program, or 2) Colorado Blues - a cognitive-behavioral program. After the group, girls return for three follow-up visits over the course of a year. The main outcomes are depressive symptoms and insulin resistance. We also are assessing stress, eating behavior, fitness, and mindfulness.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Type 2 Diabetes Depression Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Learning 2 BREATHE

Learning 2 BREATHE, Mindfulness-based group program

Group Type EXPERIMENTAL

Learning 2 BREATHE

Intervention Type BEHAVIORAL

Mindfulness-based group program

Colorado Blues

Colorado Blues, Cognitive-behavioral depression prevention group

Group Type EXPERIMENTAL

Colorado Blues

Intervention Type BEHAVIORAL

Colorado Blues, Cognitive-behavioral depression prevention group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Learning 2 BREATHE

Mindfulness-based group program

Intervention Type BEHAVIORAL

Colorado Blues

Colorado Blues, Cognitive-behavioral depression prevention group

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 12-17 years
* Female
* Overweight or obese, defined as a body mass index (BMI; kg/m2) ≥ 85th percentile for age
* Family history of type 2 diabetes or pre-diabetes in 1st degree relative (e.g., parent or sibling) or 2nd degree relative (e.g., aunt, uncle, or grandparent)
* Elevated stress/symptoms of depression as indicated by a Center for Epidemiological Studies-Depression Scale Total Score ≥ 16
* Good general health as reported by adolescent and parent/guardian
* English speaking (required for adolescent only, because the groups will be conducted in English)

Exclusion Criteria

* Pregnancy
* Current psychiatric disorder such as major depressive disorder necessitating treatment
* Type 2 diabetes as indicated by fasting glucose \> 126 mg/dL
* Use of medication affecting insulin resistance, body weight, or mood such as anti-depressants or stimulants
* Current psychotherapy or weight loss treatment
Minimum Eligible Age

12 Years

Maximum Eligible Age

17 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

Sponsor Role collaborator

Colorado State University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lauren B Shomaker, PhD

Role: PRINCIPAL_INVESTIGATOR

Colorado State University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Colorado State University

Fort Collins, Colorado, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Shomaker LB, Pivarunas B, Annameier SK, Gulley L, Quaglia J, Brown KW, Broderick P, Bell C. One-Year Follow-Up of a Randomized Controlled Trial Piloting a Mindfulness-Based Group Intervention for Adolescent Insulin Resistance. Front Psychol. 2019 May 8;10:1040. doi: 10.3389/fpsyg.2019.01040. eCollection 2019.

Reference Type DERIVED
PMID: 31133946 (View on PubMed)

Shomaker LB, Bruggink S, Pivarunas B, Skoranski A, Foss J, Chaffin E, Dalager S, Annameier S, Quaglia J, Brown KW, Broderick P, Bell C. Pilot randomized controlled trial of a mindfulness-based group intervention in adolescent girls at risk for type 2 diabetes with depressive symptoms. Complement Ther Med. 2017 Jun;32:66-74. doi: 10.1016/j.ctim.2017.04.003. Epub 2017 Apr 15.

Reference Type DERIVED
PMID: 28619307 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

http://awl.colostate.edu/

Adolescent Wellness Lab Website

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R00HD069516

Identifier Type: NIH

Identifier Source: secondary_id

View Link

13-4265H

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Encourage Healthy Families
NCT01823367 COMPLETED NA
Preventing Diabetes in Latino Families
NCT05228522 ACTIVE_NOT_RECRUITING NA